Jain Global »

Contineum Therapeutics shares owned by Jain Global

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Jain Global

Quarter filed Position value Share count Share price at filing
2026-03-31 $300k 23k 13.06
2025-06-30 $78k 20k 3.97

More positions owned by Jain Global

Spdr Gold Tr Gold Shs (GLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Gold Miners Etf (GDX)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Meta Platforms Cl A (META)
Spdr Series Trust State Street Spd (KRE)
Boeing Company (BA)
Select Sector Spdr Tr State Street Ene (XLE)
Micron Technology (MU)
Kraneshares Trust Csi Chi Internet (KWEB)
Select Sector Spdr Tr State Street Fin (XLF)
Apple (AAPL)

View all positions for Jain Global

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Vanguard Group
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Contineum Therapeutics